Recursion Pharmaceuticals Inc - Ordinary Shares - Class A


Market Cap$2.13B

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Recursion Pharmaceuticals Inc - Ordinary Shares - Class ARecursion Pharmaceuticals Inc - Ordinary Shares - Class A-60%-88%-0.1

Share Statistics

Market cap$2.13 Billion
Enterprise Value$1.89 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-1.62
Outstanding Shares230,273,797
Avg 30 Day Volume4,173,942


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-6.02
Price to Sales-
Price to Book Ratio9.7
Enterprise Value to Revenue40.81
Enterprise Value to EBIT-5.01
Enterprise Value to Net Income-6
Total Debt to Enterprise0.03
Debt to Equity0.13

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Recursion Pharmaceuticals Inc

218 employees

Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patient...